Literature DB >> 22851615

Characterization of THLE-cytochrome P450 (P450) cell lines: gene expression background and relationship to P450-enzyme activity.

Yalda Soltanpour1, Constanze Hilgendorf, Marie M Ahlström, Alison J Foster, J Gerry Kenna, Anne Petersen, Anna-Lena Ungell.   

Abstract

The hepatic SV40 large T-antigen immortalized human liver epithelial (THLE) cell line and sublines transfected with cytochromes P450 (P450s) are increasingly being used for evaluation of potential drug-induced liver injury. So far, the available information on transporter and enzyme expression in these transfected cell systems is scattered. The purpose of this study was to characterize THLE cell lines with respect to transporter and enzyme expression. The mRNA expression of 96 typical drug absorption, distribution, metabolism and excretion genes, which encode a selection of transporters, phase I and II drug-metabolizing enzymes, and nuclear hormone receptors, was investigated in five THLE cell lines transfected with individual human P450s and in mock-transfected THLE-null cells using real-time polymerase chain reaction. The majority of the analyzed genes was either absent or expressed at low levels in the THLE-null and THLE-P450 cells, apart from housekeeping genes and the individual transfected P450s. Enzyme activity measurements provided confirmatory functional data for CYP2C9 and CYP3A4. Comparison with gene expression in human liver revealed an overall much lower gene expression in the THLE cell lines. The low levels of expression of a broad range of P450 genes in the THLE cell lines highlight the value of studies undertaken with P450-expressing cell lines for investigation of mechanisms of P450 metabolite-mediated hepatotoxicity. However, when attempting to translate between data obtained in THLE cell lines in vitro and functional consequences in vivo, it is important to take account of their limited expression of genes encoding many other drug-metabolizing enzymes and hepatic transporters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851615     DOI: 10.1124/dmd.112.045815

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  mRNA transfection retrofits cell-based assays with xenobiotic metabolism.

Authors:  Danica E DeGroot; Adam Swank; Russell S Thomas; Mark Strynar; Mi-Young Lee; Paul L Carmichael; Steven O Simmons
Journal:  J Pharmacol Toxicol Methods       Date:  2018-03-16       Impact factor: 1.950

2.  Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.

Authors:  Eva Ramboer; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2015

3.  High-throughput and combinatorial gene expression on a chip for metabolism-induced toxicology screening.

Authors:  Seok Joon Kwon; Dong Woo Lee; Dhiral A Shah; Bosung Ku; Sang Youl Jeon; Kusum Solanki; Jessica D Ryan; Douglas S Clark; Jonathan S Dordick; Moo-Yeal Lee
Journal:  Nat Commun       Date:  2014-05-06       Impact factor: 14.919

Review 4.  Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.

Authors:  Alexander D Roth; Moo-Yeal Lee
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

5.  Blended electrospinning with human liver extracellular matrix for engineering new hepatic microenvironments.

Authors:  Rhiannon Grant; John Hallett; Stuart Forbes; David Hay; Anthony Callanan
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

6.  High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures.

Authors:  Jill A Franzosa; Jessica A Bonzo; John Jack; Nancy C Baker; Parth Kothiya; Rafal P Witek; Patrick Hurban; Stephen Siferd; Susan Hester; Imran Shah; Stephen S Ferguson; Keith A Houck; John F Wambaugh
Journal:  NPJ Syst Biol Appl       Date:  2021-01-27

Review 7.  The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review.

Authors:  Alican Özkan; Danielle Stolley; Erik N K Cressman; Matthew McMillin; Sharon DeMorrow; Thomas E Yankeelov; Marissa Nichole Rylander
Journal:  Micromachines (Basel)       Date:  2020-05-09       Impact factor: 2.891

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.